Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 348 of 5804
-
New heart artery treatment could save millions: hybrid strategy tested against standard stenting
Disease control Not yet recruitingThe number of deaths from heart disease is rising globally, particularly in developing countries. This condition involves the narrowing of arteries that supply blood to the heart. The most critical narrowing occurs in the left main coronary artery (LMCA), which supplies blood to …
Phase: NA • Sponsor: Hospital Sultanah Bahiyah • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy aims to boost radiation for tough pancreatic tumors
Disease control Recruiting nowThe purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Amniotic tissue grafts aim to heal chronic wounds faster
Disease control Not yet recruitingChronic wounds constitute a significant global health burden, affecting millions of individuals and contributing to increased morbidity, diminished quality of life, and rising healthcare costs. These wounds are characterized by delayed healing and are often associated with comple…
Phase: PHASE3 • Sponsor: Bardia Anvar • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Simple fluid test could replace needle biopsy for TB of the lung lining
Diagnosis Not yet recruitingTuberculosis (TB) is an endemic infectious disease in Hong Kong and a global health threat. Tuberculous pleuritis (TBP) is the most common form of extrapulmonary tuberculosis in China. Its presentation is frequently non-specific and the diagnosis is challenging due to its pauciba…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New hope for hard-to-treat lymphoma: three-drug combo enters early trials
Disease control Not yet recruitingThis trial is a proof-of-concept, pilot study, phase I/II clinical trial aimed at generating preliminary data on the combination of golcadomide, poseltinib, and rituximab.
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Heart attack patients get early cholesterol drug in landmark trial
Disease control Not yet recruitingThis project team is conducting a multicenter randomized controlled study, aiming to administer PCSK9 inhibitors subcutaneously as early as possible within 24 hours during the perioperative period of AMI (included \<24h STEMI and NSTEMI), and subsequently once every 12 weeks for …
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a simple pill before surgery beat back head and neck cancer?
Disease control Not yet recruitinghead and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects areas such as the mouth, throat, and voice box. Despite medical progress, little has changed in the care for patients with HPV-negative cancer. The standard care involves surgery followed by radiation …
Phase: PHASE2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug cocktail aims to reverse fatty liver damage in diabetics
Disease control Recruiting nowThis trial aims to evaluate the efficacy and safety of chiglitazar as a combination therapy for patients with MASH and T2DM.
Phase: PHASE2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New PTSD therapy offers hope for War-Torn ukraine
Symptom relief Recruiting nowThe Lux4UA project aims to support mental health treatment in Ukraine, especially for those who have experienced traumatic events due to the ongoing conflict and forced displacement. As rates of Post-Traumatic Stress Disorder (PTSD) rise among civilians, military personnel, and r…
Phase: NA • Sponsor: University of Luxembourg • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a stem cell spray stop radiation mouth pain?
Prevention Not yet recruitingRadiation-induced oral mucositis (RIOM) is an inevitable acute complication in radiotherapy for head and neck malignancies, characterized by a complex pathogenesis involving multiple biological processes. According to the latest data from the International Agency for Research on …
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
New study aims to outsmart relapse in aggressive blood cancers after transplant
Disease control Not yet recruitingDonor lymphocyte infusion (DLI) based on minimal residual disease (MRD) has been widely adopted worldwide to enhance the graft-versus-leukemia effect following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, there is a lack of studies comparing the effica…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Not yet recruitingThis study is an Ib/II phase clinical trial evaluating the safety and efficacy of IBI363 combined with chemotherapy as a second-line treatment for unresectable locally advanced or metastatic pancreatic cancer. Approximately 39-48 patients with unresectable locally advanced or me…
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug cocktail shows promise for rare head and neck cancer
Disease control Not yet recruitingThis study aims to conduct a prospective clinical trial investigating the use of pucotenlimab in combination with lenvatinib and temozolomide as neoadjuvant and postoperative adjuvant therapy for resectable oral and head and neck mucosal melanoma. The primary objectives are to ev…
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Weight loss drugs may free young adults from blood pressure meds
Disease control Recruiting nowHypertension is the leading risk factor for death globally, affecting approximately 30% of adults in the United Kingdom. Obesity is also a serious and ongoing epidemic, with global obesity rates having more than tripled in men and doubled in women, since 1975. In the United Kingd…
Phase: NA • Sponsor: Cambridge University Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo targets lung cancer brain tumors in 60-patient trial
Disease control Not yet recruitingThis multicenter study evaluates the efficacy and safety of furmonertinib 160mg versus furmonertinib 80mg plus chemotherapy (carboplatin + pemetrexed) as first-line treatment for EGFR-mutated NSCLC patients with brain metastases. It aims to determine which approach is more effect…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Second radiation after surgery or laser therapy shows promise for recurrent brain tumors
Disease control Recruiting nowstandard paradigm for management of patients who present with concern for recurrence of brain metastases following initial stereotactic radiosurgery (SRS).
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for aggressive lymphoma: precision therapy trial launches
Disease control Recruiting nowTo evaluate the efficacy and safety of Genetic subtype-matched targeted therapy in the treatment of treatment-naive diffuse large B-cell lymphoma with TP53 mutation.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could cutting one amino acid help fight stomach cancer?
Disease control Recruiting nowBased on existing literature, we posit that a leucine-restricted diet is safe and well-tolerated in patients with advanced gastric cancer receiving combined chemotherapy and immunotherapy. Patients adhering to this dietary regimen exhibit a significant reduction in serum leucine …
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control Recruiting nowThis is a prospective, randomized, phase II clinical study in patients with unresectable stage III-IVA esophageal squamous cell carcinoma (ESCC). Eligible patients will be randomly assigned in a 1:1 ratio to two treatment groups. The experimental group will receive 3 cycles of in…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Zunyi Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New imaging technique aims to shield healthy lungs during cancer radiation
Symptom relief Recruiting nowThis research project is testing a new treatment planning method for patients with lung cancer who will be treated with radiation therapy. This new method is called Computed Tomography (CT) ventilation imaging. It aims to help protect the healthiest parts of patient's lungs from …
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC